blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1889828

EP1889828 - Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.07.2009
Database last updated on 19.10.2024
Most recent event   Tooltip17.07.2009Application deemed to be withdrawnpublished on 19.08.2009  [2009/34]
Applicant(s)For all designated states
Teva Pharmaceutical Fine Chemicals S.R.L.
Strada Statale Briantea, Km 36, No83
23892 Bulciago / IT
[2008/08]
Inventor(s)01 / Castelli, Eugenio
Via Fontana, 26
23885 Arlate de Calco, Lecco / IT
02 / Riva, Paolo
Via Oslavia, 24
20052 Monza, Milan / IT
 [2008/17]
Former [2008/08]01 / Castelli, Eugenio
Via Fontana, 26
23885 Arlate de Calco, Lecco / IT
02 / Riva, Paolo
Via Oslavia, 24
20052 Monza, Milan / IT
Representative(s)Wong, Kit Yee, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2008/08]Wong, Kit Yee, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date07021705.405.04.2006
[2008/08]
Priority number, dateUS20050668741P05.04.2005         Original published format: US 668741 P
US20050686386P31.05.2005         Original published format: US 686386 P
US20050688406P07.06.2005         Original published format: US 688406 P
[2008/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1889828
Date:20.02.2008
Language:EN
[2008/08]
Search report(s)(Supplementary) European search report - dispatched on:EP08.01.2008
ClassificationIPC:C07C213/10, C07C217/48, A61K31/137
[2008/08]
CPC:
C07C213/10 (EP)
C-Set:
C07C213/10, C07C217/48 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/08]
TitleGerman:Stabiles Atomoxetinhydrochlorid, Herstellungsverfahren und analytische Steuerung seiner Stabilität[2008/08]
English:Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability[2008/08]
French:Chlorhydrate d'atomoxétine stable, son procédé de préparation et contrôle analytique de sa stabilité[2008/08]
Examination procedure23.11.2007Examination requested  [2008/08]
14.08.2008Despatch of a communication from the examining division (Time limit: M06)
25.03.2009Application deemed to be withdrawn, date of legal effect  [2009/34]
02.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/34]
Parent application(s)   TooltipEP06740685.0  / EP1751085
Fees paidRenewal fee
23.11.2007Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.200904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0052492  (LILLY CO ELI [US]) [X] 1-3 * page 11, line 25 - page 20, line 24; examples 1-3 *;
 [X]DE4123253  (SCHNEIDER MANFRED PROF DR [DE]) [X] 1-3,5-7 * page 3, line 24 - line 37; example 5 *;
 [X]US6541668  (KJELL DOUGLAS PATTON [US], et al) [X] 1-3,5-7 * examples 1,2 *;
 [PX]WO2006020348  (TEVA PHARM FINE CHEMICALS SRL [IT], et al) [PX] 1-3,5-7* examples 1,10,11 *;
 [X]  - SREBNIK, MORRIS ET AL, "Chiral synthesis via organoboranes. 18. Selective reductions. 43. Diisopinocampheylchloroborane as an excellent chiral reducing reagent for the synthesis of halo alcohols of high enantiomeric purity. A highly enantioselective synthesis of both optical isomers of Tomoxetine, Fluoxetine, and Nisox", JOURNAL OF ORGANIC CHEMISTRY, (1988), vol. 53, no. 13, pages 2916 - 2920, XP002390800 [X] 1-3,5-7 * page 2919, column L, line 49 - line 64 * * page 2917, column R, line 1 - line 11 *

DOI:   http://dx.doi.org/10.1021/jo00248a005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.